Lex Bakker holds a Ph.D. in Tumor Immunology from the University of Nijmegen and was a postdoctoral fellow at the DNAX Research Institute (Palo Alto, CA). Prior to joining Merus, Lex worked at Crucell NV, where he directed the preclinical and clinical development of a human antibody combination for rabies post-exposure prophylaxis.
Tumor Immunology